CYTOMEGALOVIRUS (CMV) DISEASE (D) IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) RECIPIENTS - EFFECTIVENESS OF GANCICLOVIR PROPHYLACTIC STRATEGY, CHARACTERIZATION OF CMVD RISK-FACTORS, AND COMPARISON TO HISTORICALCONTROLS

Authors
TOZE CL SHEPHERD JD SHEPHERD JD SHERLOCK CH NANTEL SH LE A FUNG HC SUTHERLAND HJ KLINGEMANN HG BARNETT MJ
Citation
Cl. Toze et al., CYTOMEGALOVIRUS (CMV) DISEASE (D) IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) RECIPIENTS - EFFECTIVENESS OF GANCICLOVIR PROPHYLACTIC STRATEGY, CHARACTERIZATION OF CMVD RISK-FACTORS, AND COMPARISON TO HISTORICALCONTROLS, Blood, 86(10), 1995, pp. 3860-3860
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
3860 - 3860
Database
ISI
SICI code
0006-4971(1995)86:10<3860:C(D(IA>2.0.ZU;2-2